全文获取类型
收费全文 | 4338篇 |
免费 | 177篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 73篇 |
妇产科学 | 64篇 |
基础医学 | 632篇 |
口腔科学 | 126篇 |
临床医学 | 285篇 |
内科学 | 1074篇 |
皮肤病学 | 35篇 |
神经病学 | 321篇 |
特种医学 | 166篇 |
外科学 | 589篇 |
综合类 | 33篇 |
预防医学 | 152篇 |
眼科学 | 85篇 |
药学 | 453篇 |
中国医学 | 2篇 |
肿瘤学 | 408篇 |
出版年
2022年 | 44篇 |
2021年 | 57篇 |
2020年 | 37篇 |
2019年 | 36篇 |
2018年 | 55篇 |
2017年 | 51篇 |
2016年 | 73篇 |
2015年 | 57篇 |
2014年 | 91篇 |
2013年 | 101篇 |
2012年 | 168篇 |
2011年 | 193篇 |
2010年 | 126篇 |
2009年 | 114篇 |
2008年 | 225篇 |
2007年 | 253篇 |
2006年 | 230篇 |
2005年 | 209篇 |
2004年 | 232篇 |
2003年 | 170篇 |
2002年 | 194篇 |
2001年 | 187篇 |
2000年 | 197篇 |
1999年 | 186篇 |
1998年 | 49篇 |
1997年 | 46篇 |
1996年 | 42篇 |
1995年 | 35篇 |
1994年 | 30篇 |
1992年 | 123篇 |
1991年 | 81篇 |
1990年 | 66篇 |
1989年 | 91篇 |
1988年 | 75篇 |
1987年 | 50篇 |
1986年 | 61篇 |
1985年 | 56篇 |
1984年 | 30篇 |
1983年 | 24篇 |
1979年 | 23篇 |
1978年 | 18篇 |
1975年 | 19篇 |
1974年 | 26篇 |
1973年 | 27篇 |
1972年 | 23篇 |
1971年 | 19篇 |
1970年 | 34篇 |
1969年 | 19篇 |
1967年 | 18篇 |
1966年 | 18篇 |
排序方式: 共有4528条查询结果,搜索用时 15 毫秒
81.
82.
Hisahara S Takano R Shoji S Okano H Miura M 《Journal of neural transmission. Supplementum》2000,(58):135-142
Oligodendrocytes are myelin forming cells in mammalian central nervous system. About 50% of oligodendrocytes (OLGs) undergo cell death in normal development. In addition, OLG cell deaths have been observed in demyelinating diseases including multiple sclerosis (MS). Clinical observations and in vitro cell culture studies have suggested that cytokines mediate OLG cell damage in multiple sclerosis (MS). Among the cytokines, tumor necrosis factor (TNF) is thought to be one of the mediators responsible for the damage of OLGs in MS. The administration of TNF-alpha to primary cultures of OLGs induced DNA fragmentation, and significantly decreased the number of live OLGs. Chemical inhibitors Ac-YVAD-CHO (a specific inhibitor of caspase-1 (ICE)-like proteases) enhanced the survival of TNF-alpha treated OLGs better than Ac-DEVD-CHO (a specific inhibitor of caspase-3 (CPP32)-like proteases). These results indicate that caspase-1-mediated cell-death pathway are activated in TNF-induced OLG cell death. Caspase-11 is involved in activation of caspase-1. Oligodendrocytes from caspase-11-deficient mice are partially resistant to TNF-induced OLG cell death. Our results suggest that the inhibition of caspase-1 sufamily may be a novel therapeutic approach to treat MS. 相似文献
83.
The present study contrasts the expressed emotion (EE) status in family members of schizophrenic patients between Bali (Indonesia) and Tokyo (Japan), the former being a non-industrialized society and the latter an industrialized society in Asia. The EE ratings of each key relative for 62 consecutively hospitalized schizophrenic patients at the Bangli State Mental Hospital (Bali) and 33 consecutively admitted schizophrenics at Komagino Hospital (Tokyo) were obtained using the Five Minute Speech Sample (FMSS) method. A significantly lower prevalence of high EE (12.9%) was observed in Bali compared with Tokyo (36.4%) (P<0.01). This result may explain the better social adjustment of schizophrenics in Bali. In addition, in Bali, to clarify the EE effect in this non-industrialized society, we examined the relationship between each key relative's EE and the patient's psychotic symptoms at admission, as assessed by the Brief Psychiatric Rating Scale (BPRS) and the Scales for the Assessment of Negative Symptoms (SANS). Moreover, the association between each family member's EE and a patient's rate of re-admission over the 1-year period following discharge was evaluated. The EE value was significantly related to the anxious-depression factor score in the BPRS, but not to either of the other factor scores in the BPRS or SANS subscales. Furthermore, EE status was not a reliable predictor of patient re-admission over the 1-year period following discharge in Bali. 相似文献
84.
Ryo Okamoto Hiroshi Takano Tatsunori Okamura Ji-Seon Park Keiji Tanimoto Takashi Sekikawa Wataru Yamamoto Alex Sparreboom Jaap Verweij Masahiko Nishiyama 《Cancer science》2002,93(1):93-102
The precise mechanisms of resistance to camptothecin (CPT)-derived DNA topoisomerase (topo I) inhibitors and the determinants remain unclear. We found that a DNA repair protein, O6 -methylguanine-DNA methyltransferase(MGMT), participated in resistance to irinotecan hydrochloride (CPT-11), its active metabolite SN-38, and a novel CPT derivative, DX-8951f. In 17 human cancer cell lines, MGMT gene expression level closely correlated with sensitivity to the CPT derivatives, and inhibition of MGMT activity by nontoxic 5 μM O6 -benzylguanine augmented the drug activity in relation to the MGMT expression levels in 8 cell lines examined. Transfection of pCR/MGMT-sense into U-251MG and pCR/MGMT-antisense into T98G and HEC-46 cells revealed that increased MGMT expression decreased the sensitivity to CPT-11, SN-38, and DX-8951f, whereas repressed MGMT expression sensitized cells to the drugs. Western analysis revealed that treatment of MGMT -expressing T98G cells with the drugs caused a decrease of both MGMT and topo I in a dose-dependent manner. Although, in the transfectants, MGMT expression did not so closely correlate with the sensitivity to drugs as to nimustine hydrochloride (ACNU), MGMT is probably an important resistance determinant to CPT derivatives, and may play some role in the topo I-mediated DNA damage and/or the repair process. 相似文献
85.
Makiyama K Masuda M Takano Y Iki M Asakura T Suwa Y Noguchi S Hosaka M 《Cancer letters》2000,151(2):193-198
We attempted to clarify the relationship between cyclin E to p27(Kip1), Ki-67 and clinicopathologic features in transitional cell bladder carcinoma. Immunohistochemical staining of archival tissue specimens of transitional cell bladder carcinoma obtained from 94 patients was performed by the labeled streptavidin-biotin-peroxidase method. Overexpression of cyclin E protein was observed in 38 of the 94 (40.4%) specimens, and was positively correlated with histological grade, Ki-67 LI and p27(Kip1) labeling index (LI). These data suggest that cyclin E may be associated with aggressive tumor growth, and may have a relationship with p27(Kip1) for the regulation of cell cycle progression in transitional cell bladder carcinoma. 相似文献
86.
Ken-ichiro Inoue Eiko Koike Seishiro Hirano Hirohisa Takano 《Toxicology and applied pharmacology》2009,237(3):306-103
The development of nanotechnology has increased the risk of exposure to types of particles other than combustion-derived particles in the environment, namely, industrial nanomaterials. On the other hand, patients with bronchial asthma are sensitive to inhaled substances including particulate matters. This study examined the effects of pulmonary exposure to a type of nano-sized carbon nanotube (multi-walled nanotubes: MWCNT) on allergic airway inflammation in vivo and their cellular mechanisms in vitro. In vivo, ICR mice were divided into 4 experimental groups. Vehicle, MWCNT (50 μg/animal), ovalbumin (OVA), and OVA + MWCNT were repeatedly administered intratracheally. Bronchoalveolar lavage (BAL) cellularity, lung histology, levels of cytokines related to allergic inflammation in lung homogenates/BAL fluids (BALFs), and serum immunoglobulin levels were studied. Also, we evaluated the impact of MWCNT (0.1-1 μg/ml) on the phenotype and function of bone marrow-derived dendritic cells (DC) in vitro. MWCNT aggravated allergen-induced airway inflammation characterized by the infiltration of eosinophils, neutrophils, and mononuclear cells in the lung, and an increase in the number of goblet cells in the bronchial epithelium. MWCNT with allergen amplified lung protein levels of Th cytokines and chemokines compared with allergen alone. MWCNT exhibited adjuvant activity for allergen-specific IgG1 and IgE. MWCNT significantly increased allergen (OVA)-specific syngeneic T-cell proliferation, particularly at a lower concentration in vitro. Taken together, MWCNT can exacerbate murine allergic airway inflammation, at least partly, via the promotion of a Th-dominant milieu. In addition, the exacerbation may be partly through the inappropriate activation of antigen-presenting cells including DC. 相似文献
87.
Suguru Odajima Toshiyuki Seki Sayako Kato Keisuke Tomita Yuichi Shoburu Eitaro Suzuki Masataka Takenaka Motoaki Saito Hirokuni Takano Kyosuke Yamada Aikou Okamoto 《Journal Of Gynecologic Oncology》2022,33(5)
ObjectiveDirect oral anticoagulants (DOACs) are increasingly being used for the treatment of cancer-associated venous thromboembolism (CAT). However, there is limited evidence of the efficacy of DOACs for the treatment of gynecological CAT. Thus, this study aimed to investigate the efficacy and safety of edoxaban for the treatment of gynecological CAT using Japanese real-world data.MethodsWe reviewed the medical records of patients with 371 gynecological cancer who received edoxaban or vitamin K antagonist (VKA) between January 2011 and December 2018.ResultsAltogether, 211 and 160 patients were treated with edoxaban and VKA, respectively. Fourteen patients (6.8%) in the edoxaban group and 22 (13.8%) in the VKA group showed recurrence of venous thromboembolism (VTE). Cumulative VTE recurrence was not significantly different between the 2 groups (p=0.340). Adverse events occurred in 15 (7.1%) and 11 (6.9%) patients in the edoxaban and VKA groups, respectively (p=0.697). Subgroup analysis of the edoxaban and VKA groups according to different tumor types, including ovarian, endometrial, and cervical cancer, showed equivalent outcomes in terms of VTE recurrence and adverse events. Patients without pulmonary embolism (PE) were mostly omitted from initial unfractionated heparin (UFH) therapy prior to administration of edoxaban. However, this did not increase the recurrence of VTE.ConclusionThis study confirmed that edoxaban is effective and safe for the treatment of gynecological CAT. This finding was consistent for different types of gynecological cancer. Additionally, initial UFH therapy prior to the administration of edoxaban may be unnecessary for patients without PE. 相似文献
88.
Kyohei Misawa Hajime Yasuda Hironari Matsuda Munechika Hara Tomonori Ochiai Daisuke Koyama Hina Takano Noriaki Iwao Michiaki Koike 《Internal medicine (Tokyo, Japan)》2022,61(22):3421
Immune checkpoint inhibitors (ICIs) are widely used for the treatment of various cancers. However, paradoxical exacerbation of neoplasms, referred to as “hyperprogressive disease,” has been reported in a proportion of patients treated with anti-programmed cell death-1 (PD-1)/PD-1 ligand (PD-L1) blockade. We herein report a case of acute adult T-cell leukemia (ATL) that developed shortly after the administration of nivolumab, a PD-1 inhibitor, to treat non-small-cell lung cancer. There were no signs of ATL before the administration of nivolumab, and seropositivity for human T-cell leukemia virus type-1 (HTLV-1) was confirmed after the development of acute ATL. We speculate that nivolumab likely contributed to the development of acute ATL. 相似文献
89.